Tunisia confirms significant increase in over 300 medication prices
Contrary to social media claims of a "malicious campaign" and "rumors," an official review confirms that the prices of 306 human-use medications in Tunisia have indeed increased. The Central Pharmacy of Tunisia PCT published official circular No. 30/2026 on July 24, 2026, revising these prices, effective immediately. The confusion arose because the PCT only published the new price list without indicating previous prices or percentage increases, making it difficult for the public to gauge the impact. The true extent of the increases became clear on August 2, 2026, when the platform Rassd published a comparative table. Notable increases include Basdene 25 mg, which rose by 556.17% from 0.762 dinars to 5 dinars; Sintrom 4 mg, up 219.9% from 1.563 dinars to 5 dinars; and Cortef 10 mg, which increased by 212.45% from 6.401 dinars to 20 dinars. Other medications like Digoxin, Ster-Dex, Levothyrox, Taver, Rifocine, Diamox, and Levothyrox 25 µg also saw significant hikes, some exceeding 100%. Fifty-two medications are now fixed at 5 or 10 dinars, contributing to substantial price jumps for previously cheaper products. The list includes treatments for chronic diseases, as well as vitamins, homeopathic products, and ointments. This marks the second major price increase in a year, following a July 2025 revision for over 280 imported medications. The Tunisian Union of Private Pharmacy Owners Spot stated they were not consulted on this new pricing structure and have been largely excluded
